Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT03375489
Official study title

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Study summary

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

Ask AI to explain this study
Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedTelehealth Palliative Care and In-person Palliative Care

The study team can explain what participation involves.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 16, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?23 U.S. locations

Locations may change over time.

Who runs it?Massachusetts General Hospital

Study sponsor

01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
Massachusetts General Hospital
Interventions being studied
Other: Telehealth Palliative Care; Other: In-person Palliative Care
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Patient Eligibility Criteria
  • Diagnosed with advanced non-small cell lung cancer being treated with non-curative intent, and informed of advanced disease within the prior twelve weeks
  • Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed \>50% of the day)
  • The ability to read and respond to questions in English or Spanish
  • Receiving primary cancer care at one of the participating sites
  • Age \> or = 18 years
  • Lives in a state where their institutions' palliative care clinicians are licensed to practice
  • Caregiver Eligibility Criteria
  • Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week
  • The ability to read and respond to questions in English or Spanish
  • Age \> or = 18 years
Reasons someone may not be able to joinExclusion criteria

Patient

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Alabama at BirminghamBirmingham, Alabama
  • City of HopeLos Angeles, California
  • University of California - San FranciscoSan Francisco, California
  • University of ColoradoAurora, Colorado
  • Emory UniversityAtlanta, Georgia
  • Northwestern University School of MedicineChicago, Illinois
  • Rush University Medical CenterChicago, Illinois
  • University of Kansas Medical CenterWestwood, Kansas
  • Johns Hopkins MedicineBaltimore, Maryland
  • Massachusetts General HospitalBoston, Massachusetts
  • Dana Farber Cancer InstituteBoston, Massachusetts
  • University of MichiganAnn Arbor, Michigan

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 16, 2025. Always confirm current availability with the study team.

View original record ↗